Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review

Abstract

CD8+ T cells play a central role in anti-tumor immunity. Naïve CD8+ T cells are active upon tumor antigen stimulation, and then differentiate into functional cells and migrate towards the tumor sites. Activated CD8+ T cells can directly destroy tumor cells by releasing perforin and granzymes and inducing apoptosis mediated by the death ligand/death receptor. They also secrete cytokines to regulate the immune system against tumor cells. Mitochondria are the central hub of metabolism and signaling, required for polarization, and migration of CD8+ T cells. Many studies have demonstrated that mitochondrial dysfunction impairs the anti-tumor activity of CD8+ T cells through various pathways. Mitochondrial energy metabolism maladjustment will cause a cellular energy crisis in CD8+ T cells. Abnormally high levels of mitochondrial reactive oxygen species will damage the integrity and architecture of biofilms of CD8+ T cells. Disordered mitochondrial dynamics will affect the mitochondrial number and localization within cells, further affecting the function of CD8+ T cells. Increased mitochondria-mediated intrinsic apoptosis will decrease the lifespan and quantity of CD8+ T cells. Excessively low mitochondrial membrane potential will cause the release of cytochrome c and apoptosis of CD8+ T cells, while excessively high will exacerbate oxidative stress. Dysregulation of mitochondrial Ca2+ signaling will affect various physiological pathways in CD8+ T cells. To some extent, mitochondrial abnormality in CD8+ T cells contributes to cancer development. So far, targeting mitochondrial energy metabolism, mitochondrial dynamics, mitochondria-mediated cell apoptosis, and other mitochondrial physiological processes to rebuild the anti-tumor function of CD8+ T cells has proved effective in some cancer models. Thus, mitochondria in CD8+ T cells may be a potential and powerful target for cancer treatment in the future.

A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma

“…Finally, mitochondrial dysfunction would lead to genomic instability, the aging process, and the occurrence and development of cancer ( 19 ). Mitochondria dysfunction in CD8+ T cells has also been demonstrated to be an essential contributing factor for cancer development and a potential target for cancer treatment ( 20 ). Therefore, an in-depth understanding of mitochondrial dysfunction in cancer is essential for developing novel effective therapeutic strategies.…”

PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets

“…However, disturbances in mitochondrial dynamics can affect CD8+ T cell function. Overall, mitochondrial abnormalities in CD8+ T cells contribute to cancer development [48]. Therefore, targeting PYCR or PYCR-related regulatory targets may be a feasible strategy for regulating immune cell infiltration in patients with KIRP.…”

The Metastatic Spread of Breast Cancer Accelerates during Sleep: How the Study Design can Affect the Results

“…(2) Tumor-targeting immune cells prevent the tumor cells' access to the bloodstream. To this end, immune cells require enough mitochondrial biogenesis to supply energy (Herbel et al, 2016;Houshyari & Taghizadeh-Hesary, 2022;L. Zhang et al, 2022).…”